These include early diagnosis through routine neonatal screening, the combination of the CFTR modulators ivacaftor, tezacaftor, and elexacaftor [6], the promulgation of evidence-based guidelines to optimize nutritional and pulmonary health, and the development of interdisciplinary treatments specific to CF [7]. The gene discussed is CFTR; the disease is cystic fibrosis.